MODD Company Profile and Key Details

MODD has shown mixed momentum, losing -0.19% over the past week and -17.94% over the past quarter, though year-to-date performance is up 30.16%. Short-term trend indicators are mixed aligned (SMA20 -1.21%, SMA50 3.91%, SMA200 -26.96%). The stock’s 14-day RSI is 48.36 (neutral), while the ATR of 0.04 points to moderate volatility. The stock remains hovering near 52-week lows, trading -65.11% below its high and over 60.75% above its low. Average 10-day trading volume of 442.64 thousand shares is significantly above the 3-month average of 168.18 thousand, indicating heightened recent market interest.

Modular Medical, Inc. has 55.27 million shares outstanding. The public float is 43.80 million shares, elevated short interest at 0.37% of float. This equals 162.39 thousand shares. The short ratio is 1.48 days. Institutional investors hold 32.03% of the float. Insiders own 2.55%. DiPerna Paul holds 2.55 million shares, MANCHESTER MANAGEMENT CO LLC has 422.00 thousand shares and Gillen Frank James has 250.00 thousand shares.

Modular Medical, Inc. generated EPS of -$0.49 over the past year. Five-year average earnings growth is 10.65%. The latest quarter delivered EPS of -$1.37. The next quarter is forecast at $nan. Next year's EPS is expected at $1.97. Modular Medical, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended June 29, 2026, missed forecasts by -49.26%. The prior quarter beat by 10.0%. Over the last six quarters, Apple has recorded several small beats. These include 8.33% in February 13, 2025.

Modular Medical, Inc. (NASDAQ:MODD) closed at $3.43 USD, gaining $0.11 (3.31%) from the previous close of $3.32. The stock is currently mid-range between its 52-week high and low $1.72 and $30.00. With a market capitalization of about $7.24 million, Modular Medical, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.07). Key stats such as the average daily volume over the past year has been around 213.44 thousand shares, in line with its 52-week average. Headquartered in San Diego, CA, Modular Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO James E. Besser, the company employs approximately 51 people and listed since February 10, 2022. Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps.

Modular Medical, Inc. trades at a P/E ratio of -0.33, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 1.69 suggesting the stock is closer to book value. The P/FCF stands at -0.25, also above market averages.

Modular Medical, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $2.87. This means the shares are trading above this model’s fair value.

Our AI price prediction model suggests that Modular Medical, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -20.7%, with price expected at $2.72 by September 02, 2026, within a range of $2.34 to $3.08 3-Month Outlook: Projected fall of -73.47%, reaching $0.91 by November 17, 2026, with a range of $0.37 to $1.37. 1-Year Outlook: Projected loss of -85.71%, with price at $0.49 by August 19, 2027, within a range of $0.00 to $0.00.

Modular Medical, Inc. (NASDAQ:MODD) shares are up 30.16% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Modular Medical, Inc. trading at a premium to the broader market with a P/E of -0.33. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $4.25, suggesting 23.91% upside. Our AI forecast model points to short-term weakness (-20.7% over two weeks), a medium-term fall (-73.47% over three months), and a longer-term loss (-85.71% over one year), with expected trading ranges indicating moderate volatility.